Weight-loss drug for clinically obese and diabetic patients goes instead to the rich and famous
Obesity experts have crowed over an effective new weight-loss drug. But rather than going to the clinically obese and diabetic people who would need it, it’s getting scarfed up by those who can afford the hefty price tag.
Derek Thompson of the Atlantic joins Here & Now‘s Scott Tong.
This article was originally published on WBUR.org.
Copyright 2023 NPR. To see more, visit https://www.npr.org.